ID   NBT-2
AC   CVCL_6545
SY   NBT2
DR   Wikidata; Q54907561
RX   PubMed=439532;
RX   PubMed=3986962;
RX   PubMed=7185004;
CC   Population: Japanese.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 13
//
RX   PubMed=7185004; DOI=10.2302/kjm.31.127;
RA   Tachibana, Masaaki
RT   "Studies on cellular adhesiveness in five different culture cell lines
RT   derived from carcinoma of the urinary bladder.";
RL   Keio J. Med. 31:127-148(1982).
//
RX   PubMed=3986962; DOI=10.1093/carcin/6.4.549;
RA   Watatani, Masahiro
RA   Ikenaga, Mituo
RA   Hatanaka, Toshihiro
RA   Kinuta, Masakatsu
RA   Takai, Shin-ichiro
RA   Mori, Takesada
RA   Kondo, Sohei
RT   "Analysis of N-methyl-N'-nitro-N-nitrosoguanidine (MNNG)-induced DNA
RT   damage in tumor cell strains from Japanese patients and demonstration
RT   of MNNG hypersensitivity of Mer xenografts in athymic nude mice.";
RL   Carcinogenesis 6:549-553(1985).
//
RX   PubMed=439532; DOI=10.5980/jpnjurol1928.70.3_351;
RA   Yamamoto, Takahiko
RT   "Establishment of a new cell line (NBT-2) derived from a human urinary
RT   bladder carcinoma and its characteristics.";
RL   Nihon Hinyokika Gakkai Zasshi 70:351-357(1979).
//